Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$2.24 - $4.18 $4,793 - $8,945
-2,140 Reduced 16.9%
10,521 $28,000
Q2 2022

Aug 08, 2022

SELL
$2.85 - $7.77 $21,759 - $59,323
-7,635 Reduced 37.62%
12,661 $36,000
Q1 2022

May 12, 2022

BUY
$5.7 - $9.3 $40,333 - $65,806
7,076 Added 53.52%
20,296 $154,000
Q4 2021

Feb 02, 2022

SELL
$8.73 - $15.27 $24,662 - $43,137
-2,825 Reduced 17.61%
13,220 $116,000
Q3 2021

Nov 12, 2021

SELL
$13.52 - $23.95 $42,926 - $76,041
-3,175 Reduced 16.52%
16,045 $223,000
Q2 2021

Aug 03, 2021

BUY
$22.12 - $32.06 $186,515 - $270,329
8,432 Added 78.16%
19,220 $465,000
Q1 2021

May 10, 2021

BUY
$26.12 - $52.17 $281,782 - $562,809
10,788 New
10,788 $345,000
Q4 2020

Feb 11, 2021

SELL
$14.05 - $29.0 $167,209 - $345,129
-11,901 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$14.17 - $19.48 $508,263 - $698,728
-35,869 Reduced 75.09%
11,901 $170,000
Q2 2020

Aug 11, 2020

BUY
$13.25 - $21.72 $59,452 - $97,457
4,487 Added 10.37%
47,770 $772,000
Q1 2020

May 08, 2020

SELL
$9.73 - $24.9 $51,335 - $131,372
-5,276 Reduced 10.87%
43,283 $624,000
Q4 2019

Feb 07, 2020

SELL
$14.22 - $23.38 $25,880 - $42,551
-1,820 Reduced 3.61%
48,559 $1.02 Million
Q3 2019

Oct 31, 2019

SELL
$22.93 - $41.06 $194,125 - $347,613
-8,466 Reduced 14.39%
50,379 $1.16 Million
Q2 2019

Aug 09, 2019

BUY
$38.73 - $52.03 $15,918 - $21,384
411 Added 0.7%
58,845 $2.37 Million
Q1 2019

Apr 24, 2019

BUY
$28.11 - $50.77 $91,048 - $164,444
3,239 Added 5.87%
58,434 $2.53 Million
Q4 2018

Jan 29, 2019

BUY
$26.22 - $56.89 $391,018 - $848,400
14,913 Added 37.02%
55,195 $1.48 Million
Q3 2018

Oct 26, 2018

BUY
$24.31 - $52.74 $979,255 - $2.12 Million
40,282 New
40,282 $1.96 Million

Others Institutions Holding CGC

About Canopy Growth Corp


  • Ticker CGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 480,284,000
  • Market Cap $3.05B
  • Description
  • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...
More about CGC
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.